Unmet Need The inventors believe this invention may address two areas of unmet need. Growth hormone Deficiency: Long-acting dosage form for recombinant human growth hormone (r-hGH) is currently lacking in the market despite the facts that r-hGH was first approved for use by FDA in 1995, the conventional dosage form in the market has a […]
Unmet Need Serotonergic psychedelics like psilocybin and LSD are known to possess considerable therapeutic potential. They exhibit impressive clinical promise for the treatment of inflammatory disease, substance use disorders, psychiatric disorders, and various neurological conditions. However, there are significant challenges, as these drugs are limited by their hallucinogenic effects, which requires close clinical supervision and […]
Bandages and gauzes are common devices used in clinical settings to treat an assortment of wounds. While bandages and gauzes are effective in treating low grade or hemorrhage wounds, they are limited in their success in treating more complex and / or chronic, non-healing wounds. These traditional wound dressings may not adequately fit all parts […]
Fortune Business Insights reports that the global fungicide market size was valued at $17.1 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 4.93% to $25.81 billion by 2028. With the expansion of the global fungicide market, which includes manufacturing benzoxaboroles in large quantities, Dr. Tomsho’s protecting group […]
Unmet Need Targeted and long-lasting formulations of chemotherapeutics with low doses and few side effects. Opportunity Simple formulations to delivery two or more therapeutics to cancers with similar pharmacokinetic profiles. Easier to manufacture than nano / micro particles. Good to use in combination with immune checkpoint inhibitors. Unique Attributes Apoptotic agent that acts independently of […]
TechTransCo, LLC d/b/a L2C Partners (“L2C Partners”) is not a registered broker-dealer or a registered investment adviser. You understand that the business plans of the companies posted on this website are furnished for your personal, noncommercial, informational purposes only, and that the inclusion of any company’s business plan (a “Company Plan”) on this website does not constitute an offer to sell, or a recommendation to buy, sell, or hold, any security of that company. To the extent that any of the information contained in any Company Plan may be deemed to be an offer to sell securities or investment advice, such information is impersonal and not directed towards any specific person. You agree and acknowledge that you are responsible for your own investment decisions with respect to any security of a company whose Company Plan is posted on this website.
L2C Partners has not reviewed any Company Plan posted on this website, and does not represent or warrant that any such Company Plan is accurate, reliable, correct or complete. THE COMPANY PLANS ARE PROVIDED "AS IS," “WHERE IS” AND “WITH ALL FAULTS,” AND L2C PARTNERS MAKES NO WARRANTY WITH RESPECT TO ANY COMPANY PLAN OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF ACCURACY, COMPLETENESS, TIMELINESS, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT, AND EXPRESSLY DISCLAIMS ALL SUCH WARRANTIES.
YOU AGREE AND ACKNOWLEDGE THAT NEITHER L2C PARTNERS NOR ITS AFFILIATES, MEMBERS, MANAGERS, OFFICERS, EMPLOYEES, BUSINESS PARTNERS, ADVISORS OR AGENTS (THE “L2C PARTIES”) SHALL HAVE ANY LIABILITY (JOINTLY OR SEVERALLY) TO YOU OR TO ANY OTHER PERSON FOR THE ACCURACY, RELIABILITY, CORRECTNESS OR COMPLETENESS OF ANY SUCH COMPANY PLAN, OR FOR ANY LOSSES, DAMAGES, EXPENSES, CLAIMS, OBLIGATIONS OR LIABILITIES, INCLUDING, WITHOUT LIMITATION, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY OR PUNITIVE DAMAGES, INCLUDING LOST PROFITS (COLLECTIVELY, THE “EXCLUDED DAMAGES”), ARISING FROM OR RELATED TO YOUR OR ANY OTHER PERSON’S USE OF OR RELIANCE ON THE CONTENT OF ANY COMPANY PLAN, WHETHER OR NOT CHARACTERIZED IN NEGLIGENCE, TORT, CONTRACT, OR OTHER THEORY OF LIABILITY, EVEN IF ANY OF THE L2C PARTIES HAVE BEEN ADVISED OF THE POSSIBILITY OF OR COULD HAVE FORESEEN ANY OF THE EXCLUDED DAMAGES. IF ANY PORTION OF THIS DISCLAIMER IS HELD TO BE UNENFORCEABLE, THEN THE L2C PARTIES' LIABILITY WILL BE LIMITED TO THE FULLEST POSSIBLE EXTENT PERMITTED BY APPLICABLE LAW.